Deschildre, Antoine <br/><br/>
Real-life long-term omalizumab therapy in children with severe allergic asthma.  [electronic resource] 

 -  The European respiratory journal  Sep 2015 
 - 856-9 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-3003 
<br/><br/><label>Standard No.: </label>10.1183/09031936.00008115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anti-Asthmatic Agents--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Asthma--drug therapy<br/>Child<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections, Subcutaneous<br/>Long-Term Care<br/>Male<br/>Omalizumab--therapeutic use<br/>Recurrence<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Treatment Outcome